Pediatric Acute Respiratory Virus Hospitalizations: A Population-Based Cohort Study, 2017–2024 - Top-Institutions - MDSpire

Pediatric Acute Respiratory Virus Hospitalizations: A Population-Based Cohort Study, 2017–2024

  • By

  • Tiffany Fitzpatrick

  • Sarah A Buchan

  • Sanjay Mahant

  • Longdi Fu

  • Jeffrey C Kwong

  • Therese A Stukel

  • Astrid Guttmann

  • April 26, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    The Hospital for Sick Children (SickKids)
    The Hospital for Sick Children (SickKids)

    Toronto, Ontario

    Key Differentiators

    • Pediatric Infectious Diseases
    • Epidemiology
    • Pediatric Respiratory Medicine

  • #2

    Children's Hospital of Philadelphia (CHOP)
    Children's Hospital of Philadelphia (CHOP)

    Philadelphia, Pennsylvania

    Key Differentiators

    • Pediatric Infectious Diseases
    • Epidemiology
    • Pediatric Pulmonology

  • #3

    Johns Hopkins Children's Center
    Johns Hopkins Children's Center

    Baltimore, Maryland

    Key Differentiators

    • Pediatric Infectious Diseases
    • Epidemiology
    • Public Health

  • #4

    University of Washington Seattle Children’s Hospital
    University of Washington Seattle Children’s Hospital

    Seattle, Washington

    Key Differentiators

    • Pediatric Infectious Diseases
    • Epidemiology
    • Respiratory Medicine

  • #5

    Boston Children’s Hospital
    Boston Children’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pediatric Infectious Diseases
    • Epidemiology
    • Pulmonology

Original Source(s)

Pediatric Acute Respiratory Virus Hospitalizations: A Population-Based Cohort Study, 2017–2024

  • by Tiffany Fitzpatrick, Sarah A Buchan, Sanjay Mahant, Longdi Fu, Jeffrey C Kwong, Therese A Stukel, Astrid Guttmann

  • April 26, 2025

Related Content

Ebola at the World Cup? Here’s what we should actually worry about

Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals